Quick Overview
- LRCX shares climbed approximately 1.42% to reach $310.10 during Friday’s trading session, supported by widespread technology sector gains
- Fourth-quarter revenue reached $6.72 billion, surpassing projections, while earnings per share of $1.82 exceeded the anticipated $1.68
- First-quarter 2027 revenue outlook of $7.70B–$8.50B significantly outpaced the $7.09B Street consensus
- Institutional stakeholders control 84.61% of shares, with Eldred Rock Partners expanding its position by 6.4%
- Wall Street analysts maintain a “Moderate Buy” rating with a mean price objective of $358.47
Shares of Lam Research (LRCX) advanced roughly 1.42% to settle at $310.10 on Friday, riding a wave of strength across the technology sector. The Nasdaq Composite jumped 1.12% while the S&P 500 gained 0.63%, with tech stocks leading the charge with a 1.20% increase.
Lam Research Corporation, LRCX
The day’s price action reflected broader market sentiment rather than fresh company announcements. Eight out of eleven S&P 500 sectors finished in positive territory, with advancing issues outnumbering decliners by approximately 2.7 to one.
The semiconductor equipment manufacturer has maintained upward momentum following its fiscal fourth-quarter results, unveiled on July 29. Those numbers provided substantial fuel for investor optimism.
Lam reported fourth-quarter revenue of $6.72 billion, topping analyst projections of $6.67 billion. Adjusted earnings per share registered at $1.82, surpassing the $1.68 Street estimate. Year-over-year revenue expanded 30%.
The company achieved a gross margin of 51.7% and operating margin of 37.4%. Lam concluded the quarter holding $5.6 billion in cash, cash equivalents and restricted cash.
Chief Executive Tim Archer highlighted that the company achieved “record revenue, operating margin and earnings per share” during the June quarter, attributing performance to AI-driven demand transforming the semiconductor manufacturing equipment landscape.
First-Quarter Outlook Crushes Wall Street Forecasts
The forward guidance emerged as the headline attraction. Lam projected first-quarter 2027 revenue between $7.70 billion and $8.50 billion, substantially exceeding the $7.09 billion Wall Street consensus. Earnings per share guidance of $2.00 to $2.30 similarly outpaced the $1.83 analyst estimate.
Market watchers anticipate the company will deliver full-year earnings per share of $9.24 for the ongoing fiscal year.
Major Investors Continue Accumulating Shares
Eldred Rock Partners expanded its LRCX holdings by 6.4% during the second quarter, acquiring an additional 4,289 shares to reach a total of 71,251. The position now carries a value of approximately $30.9 million and represents 6.6% of the firm’s investment portfolio.
Multiple institutional investors increased their holdings in recent quarters. Rokos Capital Management boosted its position by 42% in the first quarter. Aware Super established a fresh stake valued at around $60 million. Institutional investors and hedge funds collectively control 84.61% of outstanding shares.
On the insider front, two board members executed stock sales through pre-established Rule 10b5-1 trading plans. Director Eric Brandt divested 54,500 shares at $350.80 in June, while Director Abhijit Talwalkar sold 18,282 shares at $335.00 in July. Combined insider sales during the previous 90 days totaled 80,441 shares valued at approximately $27.6 million.
LRCX has traded within a 52-week band of $94.11 to $438.50. The stock currently sits approximately 26% above its 200-day moving average but remains roughly 8.5% beneath its 50-day moving average.
The Relative Strength Index registers at 48, indicating neutral momentum. Critical support levels emerge near $298.50, proximate to the 100-day moving average.
Morgan Stanley preserved its Overweight rating while reducing its price target to $367. Wells Fargo and B. Riley maintained positive ratings with $350 targets. Mizuho rates the equity Outperform with a $400 objective. The consensus average price target stands at $358.47.
LRCX concluded Friday’s session at $310.10, advancing 1.42%.





